CLOV vs IBRX
Clover Health Investments Corp (CLOV) versus Immunitybio Inc (IBRX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IBRX revenue for 2024-12-31 was $14.7M. Net income was -$413.6M. Revenue was up 2270.6% from 2023-12-31 to 2024-12-31. IBRX currently screens at market cap $7.88B.
CLOV currently screens at market cap $1.55B. IBRX currently screens at market cap $7.88B.
Not investment advice. Open the CLOV and IBRX stock pages for the full models.
Not investment advice.